|
|
|
|
|
HONG KONG, Apr 26, 2022 - (ACN Newswire) - Legend Capital's portfolio company Lunit, a Korean Medical AI company, recently announced a preliminary approval from the Korea Exchange for initial public offering (IPO) on the KOSDAQ market, and it plans to submit a registration statement within the second quarter of 2022.
Founded in 2013, Lunit is a company with the world's top-notch AI technology focusing on R&D of medical software to assist tumor diagnosis and treatment. It utilizes advanced AI technology to process medical image data, which helps doctors to make accurate clinical decisions in diagnosis and treatment. Lunit's flagship products are Lunit INSIGHT, an AI image analysis solution for cancer screening, and Lunit SCOPE, an AI biomarker platform for cancer treatment.
According to Korean media reports, Lunit is considered one of the most promising medical AI IPOs in Korea in the first half of 2022. After the listing, Lunit plans to use the secured funding for R&D of AI products and global market development, laying the cornerstone for sustainable growth.
Lunit has partnered with global medical device giants such as GE Healthcare, Philips, and FujiFilm to supply products to about 600 medical sites in more than 40 countries worldwide. In addition, Lunit is also focusing on its biomarker business by signing an exclusive business contract with Guardant Health, a leading global liquid biopsy company.
Brandon Suh, CEO of Lunit, said: "Lunit is the first deep learning-based medical AI company in Korea with a specialized AI research team and medical team, developing AI solutions for cancer diagnosis and treatment. As our AI technologies and products are acknowledged globally, we will strive to continuously grow and pioneer the global medical AI market by going public."
Legend Capital has invested in Lunit 4 times in 2018, 2019, and 2021; it is one of the company's main investors and has long supported its development. Closely following the deep integration of medical and health industry and technology, Legend Capital has built a solid portfolio in medical AI sector in recent years. In addition to Lunit, Legend Capital also invested in a number of other leading medical AI companies, such as Xbiome, an AI-based microbiome drug development company, StoneWise, an AI technology-driven innovative drug R&D platform company, Deepwise Healthcare, an AI medical imaging company, Deep Informatics++, an AI medical pathological diagnosis company, Genome Wisdom, a genomic big data company, and Ayshealth Technology, an AI medical chronic disease management system company.
Topic: Press release summary
Source: Legend Capital
Sectors: BioTech, PE, VC & Alternatives, Artificial Intel [AI]
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
| Legend Capital |
| July 15, 2024 17:10 HKT/SGT |
|
Legend Capital's Portfolio Company Singfilm Solar Achieves Breakthrough in Perovskite Solar Cell Efficiency |
| July 5, 2024 18:41 HKT/SGT |
|
Legend Capital Portfolio Company Yonz Technology Lists on the Main Board of the Shanghai Stock Exchange |
| June 27, 2024 11:48 HKT/SGT |
|
Legend Capital's Portfolio Company Aidite Lists on the ChiNext Successfully |
| May 29, 2024 10:38 HKT/SGT |
|
Legend Capital Portfolio Company Qunabox Group Lists on the Main Board of the HKEX Successfully |
| Dec 19, 2023 15:45 HKT/SGT |
|
Legend Capital Portfolio Company ZKH Lists on the New York Stock Exchange Successfully |
| Oct 10, 2023 13:55 HKT/SGT |
|
Co-led by Legend Capital, Leadrive Completes Series D Financing Round |
| Sept 27, 2023 15:19 HKT/SGT |
|
Legend Capital Portfolio Company TUHU Car Lists on the Main Board of the HKEX Successfully |
| Aug 18, 2023 20:09 HKT/SGT |
|
Legend Capital Portfolio: Nuclei, the World's First RISC-V CPU IP Vendor, Accomplishes ISO 26262 ASIL-D Product Certificate |
| Aug 18, 2023 16:43 HKT/SGT |
|
Backed by Legend Capital, the Chinese Pet Food Industry Leader Gambol Pet Goes Public Successfully |
| July 31, 2023 19:48 HKT/SGT |
|
Exploring New Collaborative Opportunities! The Indonesia-China Healthcare and Biotech Investment Forum Successfully Held |
| More news >> |
 |
|
|
|
